Childhood atopic eczema consensus document

South African Medical Journal

Volumn 95, Issue 6 II, 2005, Pages 435-440

  Manjra, A I ^a   du Plessis, P ^a   Weiss, R ^a   Motala, C M ^a   Potter, P C ^a   Raboobee, N ^a   Ndlova, N ^a   Davis, M ^a   Weinberg, E G ^a  

^a Allergy Society of South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DIFLUCORTOLONE VALERATE; EMOLLIENT AGENT; FLUOCINOLONE ACETONIDE; GAMMA INTERFERON; HERBACEOUS AGENT; HYDROCORTISONE BUTYRATE; IMMUNOGLOBULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NERISONE FORTE; PAPAVERINE; PIMECROLIMUS; PLACEBO; PROBIOTIC AGENT; STEROID; TACROLIMUS; THEOPHYLLINE; THYMOPENTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; ACUPUNCTURE; ALLERGIC RHINITIS; ALTERNATIVE MEDICINE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BATH; BLOOD ANALYSIS; CATARACT; CHILDHOOD DISEASE; CLIMATOTHERAPY; CLINICAL TRIAL; CONSENSUS; CUSHING SYNDROME; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG INDICATION; DRUG POTENCY; ENVIRONMENTAL FACTOR; FOOD ALLERGY; GLAUCOMA; GROWTH RETARDATION; HAIR GROWTH; HEALTH CARE ORGANIZATION; HOMEOPATHY; HUMAN; HYPOPIGMENTATION; IMMUNOMODULATION; MASSAGE; NOMENCLATURE; PATHOGENESIS; PHOTOTHERAPY; PREVALENCE; PRICK TEST; PRURITUS; PUVA; ROSACEA; SIDE EFFECT; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN TUMOR; SYSTEMATIC REVIEW; TELANGIECTASIA;

BATHING BEACHES; CALCINEURIN; CHILD; COMPLEMENTARY THERAPIES; DERMATITIS, ATOPIC; EMOLLIENTS; FOOD HYPERSENSITIVITY; HISTAMINE H1 ANTAGONISTS; HUMANS; PHOTOTHERAPY; RADIOALLERGOSORBENT TEST; SKIN TESTS;

EID: 23044488679     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Johansson SGO, Bieber B, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TAE, Ring J, Thien F, van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
2. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103: 125-138.
3. Todd G, Saxe N, Milne J, Tolosana S, Williams H. Prevalence of atopic dermatitis in Xhosa children living in rural, peri-urban, and urban areas. Curr Allergy Clin Immunol 2004; 17: 140.
4. Sugiura H, Umemotoa N, Deguchi H, et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol 1998; 78: 293.
5. Sporik R, Hill D, Husking CS. Specificity of allergen skin prick testing in predicting positive open food challenges to milk, egg, and peanut in children. Clin Exp Allergy 2000; 30: 1540-1546.
6. Gdalevich M, Robin G, Mimouni D, Grotto I, Shpilberg O, Ashkenazi I. Breastfeeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001; 45: 520-527.
7. Businco L. Is soya allergy overestimated? Paediatr Asthma Allergy Immunol 1993; 7: 73-76.
8. Sampson HA. Food sensitivity and the pathogenesis of atopic dermatitis. J R Soc Med 1997; 90: 3-9.
9. Sampson HA, Ho DG. Relationship between food specific IgE concentrations and risk of positive food challenges in children and adolescents. J Allergy Clin Immunology 1997; 100: 444-451.
10. Vanto T, Juntunen Backman K, Kalimo K, Klemola T, Varjonen E. The patch tests, skin prick test and serum IgE as diagnostic tools in cow milk allergy in infants. Allergy 1999; 54: 837-842.
11. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on paediatric atopic dermatitis. J Acad Dermatol 2003; 49: 1088-1095.
12. McHenry PM, Williams HC, Bingham EA. Fortnightly review: Management of atopic eczema. BMJ 1995; 310: 843-847.
13. Williams HC. In: Stevens ARJ, ed. Dermatology. Health Care Needs Assessment. Oxford: Radcliffe Medical Press, 1997: 261-348.
14. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
15. Marks R. How to measure the effects of emollients. J Dermatol Treat 1997; 8: 125-118.
16. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y. International consensus conference on atopic dermatitis 11 (ACCAD11). Br J Dermatol 2003; 148: suppl. 63, 3-10.
17. Abeck D, Atrom K. Optimal management of atopic dermatitis. Am Clin Dermatol 2000; 1: 41-46.
18. Wilhelm KP, Scholerman A. Efficacy and tolerability of a topical preparations containing 10% urea in patients with atopic dermatitis. Acta Dermatol 1998; 24(1-2): 26-30.
19. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of potent topical corticosteroids. Prolonged use of a mild topical steroid in children with mild or moderate atopic eczema. BMJ 2002; 324: 768-771.
20. Sidbury R, Hanifin JM. Old, new, and emerging therapies for topic dermatitis. Dermatol Clin 2000; 18: 1-11.
21. Tofte SJ, Hanifin JM. Current management and therapy of atopic dermatitis. J Am Acad Dermatol 2001; 44: S13-16.
22. Munday J, Bloomfield R, Goldman M, et al. Chlorphoneramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis. Dermatology 2002; 205(1): 40-45.
23. Leung DYM. Atopic dermatitis. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ, eds. Pediatric Allergy. St Louis: Mosby, 2003: 569-570.
24. Wahlgren CF, Hagermark O. Bergstrom R. The antipruritic effect of a sedative and a non sedative antihistamine in atopic dermatitis. Br J Dermatol 1990; 122: 545-551.
25. Holgate ST, Church MK. Eczema and contact dermatitis. In: Allergy. Mosby Wolfe, 1995. Chapter 23, 23.1-24.10.
26. Kemp JP. Tolerance to antihistamine is it a problem? Ann Allergy 1989; 63: 621-623.
27. Prose NS. Atopic dermatitis. In: Rudolph CD, Rudolph AM, Hostetter MK, eds. Pediatrics. 21st ed. McGraw Hill, 2000: 1177-1179.
28. Grassberger M, Baumruker T, Enz A, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 1999; 141: 264-273.
29. Zuberbier T, Chong S. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 2001; 108: 275-280.
30. Kapp A, Papp K, Bingham A, et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 2002; 110: 279-284.
31. Grundmann-Kollmann M, Behrens S, Podda M, et al. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999; 40: 995-997.
32. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 2004; 50: 391-404.
33. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ. Cyclosporin for severe childhood atopic dermatitis. Short course versus continuous therapy. Br J Dermatol 2000; 142: 52-58.
34. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE.. Systemic interferon-gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189-197.
35. Reinhold U, Kukel S, Brzoska J, Kreysel HW. Systemic interferon-gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993; 29: 58-63.
36. Musial J, Milewski M, Undas A, Kopinski P, Duplaga M, Szczeklik A. Interferon-gamma in the treatment of atopic dermatitis: influence on T-cell activation. Allergy 1995; 50: 520-523.
37. Meggit SJ, Reynolds NJ. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001; 26: 369-375.
38. Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, cross over trial. Br J Dermatol 2002; 147: 324-330.
39. Kalilmaki M, Salminen S, Poussa T, Isolauri E. Probiotics and the prevention of atopic disease: a 4 year placebo controlled study. Lancet 2003, 361: 1869-1871.